Sungwun Pharmacopia
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sungwun Pharmacopia - overview
Established
2007
Location
Seongnam, Gyeonggi, South Korea
Primary Industry
Biotechnology
About
Based in Korea, and established in 2007, Sungwun Pharmacopia Co. , Ltd. is a pharmaceutical company that provides products including vitamin tablets, healthy food ingredients, and cosmetics products. The company established a GMP plant for APIs and pharmaceutical Intermediates in Indonesia in 2017.
The company has cooperated with PT. Kimia Farma. In September 2016, the company raised KRW 8 billion in venture funding from returning investors AJU IB Investment and Kiwoom Investment, and new investors Company K Partners, Findvalue Asset Management, and SBI Investment Korea. The company built a platform for developing new biopharmaceutical raw materials and synthetic raw materials.
The products provided by the company include APIs, intermediates and ingredients, finished products, and CDO/CMO/CRO. The R&D center of the company has been developing synthetic products focusing on intermediates, raw materials, electronic materials, cosmetics raw materials and bio products such as fermented microorganisms, enzymes, and human-derived microorganism.
Current Investors
AJU IB Investment, Kiwoom Investment, SBI Investment Korea
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals
Website
www.sungwun.net
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Sungwun Pharmacopia - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 |
|---|---|---|---|---|---|
| Revenue (USD) | 13,008,738,640 | 13,504,501,282 | - | - | - |
| % Revenue Growth (YoY) | - | 3.8% | - | - | - |
| EBITDA (USD) | 813,923,492 | 383,014 | - | - | - |
| Operating Income (USD) | 790,355,627 | (108,741,946) | - | - | - |
| Operating Margin | 6.1% | (0.8%) | - | - | - |
| % EBITDA Margin | 6.3% | 0.0% | - | - | - |
| NET Income (USD) | 113,221,428 | (4,204,053,647) | - | - | - |
| % Net Margin | 0.9% | (31.1%) | - | - | - |
Sungwun Pharmacopia - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.